These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36878320)

  • 41. Formulation Development and Molecular Mechanism Characterization of Long-Acting Patches of Asenapine for Efficient Delivery by Combining API-ILs Strategy and Controlled-Release Polymers.
    Ren S; Liu C; Sun Y; Zhang Y; Ruan J; Fang L
    J Pharm Sci; 2023 Jul; 112(7):1850-1862. PubMed ID: 36858176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach.
    Mannam R; Yallamalli IM
    Recent Pat Drug Deliv Formul; 2017; 11(3):187-197. PubMed ID: 29189185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations.
    Caffarel-Salvador E; Tuan-Mahmood TM; McElnay JC; McCarthy HO; Mooney K; Woolfson AD; Donnelly RF
    Int J Pharm; 2015 Jul; 489(1-2):158-69. PubMed ID: 25940042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
    Baviskar DT; Parik VB; Jain DJ
    PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Directly Compressed Tablets: A Novel Drug-Containing Reservoir Combined with Hydrogel-Forming Microneedle Arrays for Transdermal Drug Delivery.
    McAlister E; Dutton B; Vora LK; Zhao L; Ripolin A; Zahari DSZBPH; Quinn HL; Tekko IA; Courtenay AJ; Kelly SA; Rodgers AM; Steiner L; Levin G; Levy-Nissenbaum E; Shterman N; McCarthy HO; Donnelly RF
    Adv Healthc Mater; 2021 Feb; 10(3):e2001256. PubMed ID: 33314714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design and evaluation of patches for transdermal delivery of losartan potassium.
    Baviskar DT; Parik VB; Gupta HN; Maniyar AH; Jain DK
    PDA J Pharm Sci Technol; 2012; 66(2):126-35. PubMed ID: 22492598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integration of metformin-loaded MIL-100(Fe) into hydrogel microneedles for prolonged regulation of blood glucose levels.
    Feng M; Li Y; Sun Y; Liu T; Yunusov KE; Jiang G
    Biomed Phys Eng Express; 2024 May; 10(4):. PubMed ID: 38670077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissolving Microneedles Integrated With Liquid Crystals Facilitate Transdermal Delivery of Sinomenine Hydrochloride.
    Gui Z; Wu X; Wang S; Cao Y; Wan J; Shan Q; Yang Z; Zhang J; Gui S
    J Pharm Sci; 2017 Dec; 106(12):3548-3555. PubMed ID: 28826880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination of ion-pair strategy and chemical enhancers for design of dexmedetomidine long-acting patches: Dual action mechanism induced longer controlled release and better delivery efficiency.
    Sun Y; Liu C; Ren S; Zhang Y; Ruan J; Fang L
    Eur J Pharm Biopharm; 2023 Feb; 183():47-60. PubMed ID: 36565969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of film-forming gel containing nanoparticles for transdermal drug delivery.
    Ngo HV; Tran PHL; Lee BJ; Tran TTD
    Nanotechnology; 2019 Oct; 30(41):415102. PubMed ID: 31261146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of a Long-Acting Rivastigmine Transdermal Delivery System: Based on Computational Simulation.
    Han X; Liu J; Hu X; Wang W; Wang Q
    AAPS PharmSciTech; 2022 Jan; 23(1):54. PubMed ID: 35028813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing the Transdermal Delivery of 'Next Generation' Variable New Antigen Receptors Using Microarray Patch Technology: a Proof-of-Concept Study.
    Hutton ARJ; Ubah O; Barelle C; Donnelly RF
    J Pharm Sci; 2022 Dec; 111(12):3362-3376. PubMed ID: 36037879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eprinomectin nanoemulgel for transdermal delivery against endoparasites and ectoparasites: preparation,
    Mao Y; Chen X; Xu B; Shen Y; Ye Z; Chaurasiya B; Liu L; Li Y; Xing X; Chen D
    Drug Deliv; 2019 Dec; 26(1):1104-1114. PubMed ID: 31735104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved transdermal delivery of valsartan using combinatorial approach of polymeric transdermal hydrogels and solid microneedles: an
    Enggi CK; Satria MT; Nirmayanti N; Usman JT; Nur JF; Asri RM; Djide NJN; Permana AD
    J Biomater Sci Polym Ed; 2023 Feb; 34(3):334-350. PubMed ID: 36063003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two-phase delivery using a horse oil and adenosine-loaded dissolving microneedle patch for skin barrier restoration, moisturization, and wrinkle improvement.
    Yang H; Kim S; Jang M; Kim H; Lee S; Kim Y; Eom YA; Kang G; Chiang L; Baek JH; Ryu JH; Lee YE; Koh J; Jung H
    J Cosmet Dermatol; 2019 Jun; 18(3):936-943. PubMed ID: 30160014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
    Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
    Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.
    Jain SK; Gupta Y; Jain A; Rai K
    Drug Deliv; 2008; 15(3):141-7. PubMed ID: 18379926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatially controlled coating of continuous liquid interface production microneedles for transdermal protein delivery.
    Caudill CL; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2018 Aug; 284():122-132. PubMed ID: 29894710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.